Hepion Pharms Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 06-2017 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,923 | 2,832 | 5,954 | 12,983 | 7,404 |
| TOTAL | $14,389 | $2,968 | $6,062 | $13,193 | $7,895 |
| Non-Current Assets | |||||
| PPE Net | 57 | 32 | 57 | 68 | 81 |
| Intangibles | 1,871 | 1,871 | 1,871 | 1,871 | 1,871 |
| Other Non-Current Assets | 4,295 | 3,318 | 3,263 | 3,253 | 3,260 |
| TOTAL | $6,223 | $5,221 | $5,191 | $5,192 | $5,212 |
| Total Assets | $20,612 | $8,189 | $11,253 | $18,385 | $13,107 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,440 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 492 | 748 | 1,557 | 1,627 | 4,252 |
| Accrued Expenses | 851 | 661 | 1,047 | 1,318 | 821 |
| TOTAL | $1,610 | $2,850 | $2,604 | $2,945 | $5,084 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,976 | 2,994 | 4,050 | 5,112 | 5,436 |
| TOTAL | $3,385 | $3,364 | $4,946 | $6,382 | $6,706 |
| Total Liabilities | $4,995 | $6,214 | $7,550 | $9,327 | $11,789 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9 | 0 | N/A | N/A | N/A |
| Common Shares | 0 | 0 | 1 | 8 | 3 |
| Retained earnings | -83,752 | -76,464 | -67,015 | -59,504 | -44,613 |
| Other shareholders' equity | 856 | 856 | 1,040 | 1,040 | 13,700 |
| TOTAL | $15,617 | $1,975 | $3,703 | $9,058 | $1,318 |
| Total Liabilities And Equity | $20,612 | $8,189 | $11,253 | $18,385 | $13,107 |